Author:
Arlett Peter,Portier Geraldine,de Lisa Roberto,Blake Kevin,Wathion Noel,Dogne Jean-Michel,Spooner Almath,Raine June,Rasi Guido
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference8 articles.
1. Mullard, A. Unleashing the Mini-Sentinel. Nature Rev. Drug Discov. 11, 255–257 (2012).
2. European Medicines Agency. EMA recommends 81 medicines for marketing authorisation in 2013. European Medicines Agency
[online]
, (2014).
3. Eichler, H. G. et al. Adaptive licensing: taking the next step in the evolution of drug approval. Clin. Pharmacol. Ther. 91, 426–437 (2012).
4. Prieto, L. et al. Evaluation of the effectiveness of risk minimization measures. Pharmacoepidemiol. Drug Saf. 21, 896–899 (2012).
5. International Conference of Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline Periodic Benefit-Risk Evaluation Report (PBRER) E2C (R2). ICH
[online]
, (2012).
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献